Teriparatide (Forteo) is a synthetic version of the human parathyroid hormone, which helps to regulate calcium metabolism. It promotes the growth of new bone, while other osteoporosis medications improve bone density by inhibiting bone resorption, or breakdown. It is the only osteoporosis medicine approved by the FDA that rebuilds bone.
Forteo should be used only in men with osteoporosis and postmenopausal women.
Reality: Fractures in individuals over the age of 50 can be the first sign of weak bones from osteoporosis or low bone mass. Each year, 1.5 million older Americans suffer a bone fracture due to osteoporosis. Half of all women over 50, and a quarter of all men, will suffer an osteoporosis-related fracture sometime in their remaining life. And the problem is increasing: the surgeon general estimates that by 2020, half of all Americans over 50 will be at risk for bone fractures from osteoporosis and...
Teriparatide (Forteo) is self-injected into the skin. Because long-term safety is not yet established, it is only FDA-approved for 24 months of use. It reduces spine fractures in women with known osteoporosis, but reduction of hip fracture risk is currently unproven.
Who Should Take Forteo?
Men who have osteoporosis and postmenopausal women can take Forteo.
Forteo is not used to prevent osteoporosis or to treat mild osteoporosis.
This drug should be used if you've had at least one bone fracture due to thinning bones, you are at high risk of fractures, or you haven't responded to other osteoporosis therapies.